A norepinephrine–dopamine releasing agent (NDRA) is a type of drug which induces the release of norepinephrine (and epinephrine) and dopamine in the body...
7 KB (556 words) - 21:37, 14 January 2025
including norepinephrine–dopamine releasing agents (NDRAs) like amphetamine and methamphetamine, serotonin–norepinephrine–dopamine releasing agents (SNDRAs)...
29 KB (3,168 words) - 01:44, 13 March 2025
releasing agent Serotonin releasing agent Dopamine releasing agent Serotonin–norepinephrine releasing agent Norepinephrine–dopamine releasing agent...
18 KB (1,747 words) - 15:13, 13 February 2025
methylphenidate and bupropion. A closely related type of drug is a norepinephrine–dopamine releasing agent (NDRA). Many NDRIs exist, including the following: Amineptine...
5 KB (463 words) - 05:51, 28 January 2025
serotonin–norepinephrine–dopamine releasing agent (SNDRA), also known as a triple releasing agent (TRA), is a type of drug which induces the release of serotonin...
4 KB (378 words) - 15:13, 13 February 2025
100 nM. Monoamine releasing agent Serotonin releasing agent Dopamine releasing agent Serotonin–norepinephrine–dopamine releasing agent Blough BE, Decker...
20 KB (1,675 words) - 17:13, 9 April 2025
serotonin–norepinephrine reuptake inhibitor (SNRI). Monoamine releasing agent Serotonin releasing agent Norepinephrine releasing agent Serotonin–dopamine releasing...
1 KB (108 words) - 15:12, 13 February 2025
– non-selective serotonin receptor agonist, serotonin–norepinephrine–dopamine releasing agent (SNDRA), and weak RIMA Etryptamine [α-Ethyltryptamine (αET)]...
18 KB (1,537 words) - 20:49, 7 May 2025
releasing agent (SRA) is a type of drug that induces the release of serotonin into the neuronal synaptic cleft. A selective serotonin releasing agent...
72 KB (8,007 words) - 10:08, 21 May 2025
List of investigational attention deficit hyperactivity disorder drugs (section Norepinephrine–dopamine releasing agents)
[modified release capsules] (HLD-900, HLD-100) – norepinephrine–dopamine releasing agent Dopamine [intranasal] (DopaMat, MPP-18) – dopamine receptor agonist...
42 KB (3,170 words) - 11:22, 10 March 2025
reinforcing and cocaine-like effects of dopamine releasing agents (DRAs) with varying capacities to release norepinephrine and serotonin in rodents and monkeys...
114 KB (12,379 words) - 00:02, 10 May 2025
Phenylpiperazine (category Serotonin-norepinephrine releasing agents)
of as an imbalanced serotonin–norepinephrine releasing agent (SNRA) or serotonin–norepinephrine–dopamine releasing agent (SNDRA). Other homologues and...
7 KB (516 words) - 13:40, 30 March 2025
releasing two or more neurotransmitters Norepinephrine–dopamine releasing agent (NDRA) (e.g., amphetamine, methamphetamine) Serotonin–norepinephrine releasing...
263 KB (22,099 words) - 23:59, 9 May 2025
3-Chloromethcathinone (category Serotonin-norepinephrine-dopamine releasing agents)
concentration of dopamine, norepinephrine and serotonin in the synaptic cleft. Additionally 3-CMC and other mephedrone analogs are monoamine releasing agents (MRAs)...
18 KB (1,936 words) - 08:40, 12 March 2025
Lisdexamfetamine (category Norepinephrine-dopamine releasing agents)
functional impairments involve impaired dopamine neurotransmission in the mesocorticolimbic projection and norepinephrine neurotransmission in the noradrenergic...
48 KB (15,329 words) - 21:06, 22 May 2025
Phentermine (category Norepinephrine-dopamine releasing agents)
component of the "fen-phen" combination. Phentermine is an norepinephrine and dopamine releasing agent (NDRA) and produces stimulant, rewarding, and appetite...
44 KB (4,003 words) - 20:38, 30 March 2025
Phenylalaninol (category Norepinephrine-dopamine releasing agents)
psychostimulant and selective norepinephrine releasing agent (NRA) or norepinephrine-preferring norepinephrine–dopamine releasing agent (NDRA). The EC50Tooltip...
8 KB (573 words) - 20:07, 26 March 2025
phenylmorpholines with similar structure, it likely acts as a norepinephrine-dopamine releasing agent and may produce effects similar or slightly different to...
2 KB (108 words) - 15:41, 24 February 2025
Phenylpropylamine (category Norepinephrine-dopamine releasing agents)
(SAR) of phenethylamine and amphetamine MRAs. It acts as a norepinephrine–dopamine releasing agent (NDRA). However, phenylpropylamine is dramatically less...
10 KB (695 words) - 07:51, 27 February 2025
EDMA (category Serotonin-norepinephrine-dopamine releasing agents)
serotonin–norepinephrine–dopamine releasing agent (SNDRA) with EC50Tooltip half-maximal effective concentration values of 117 nM for serotonin release, 325 nM...
5 KB (332 words) - 08:09, 16 May 2025
2-Phenylmorpholine (category Norepinephrine-dopamine releasing agents)
are monoamine releasing agents (MRAs) and psychostimulants. 2-Phenylmorpholine itself is a potent norepinephrine–dopamine releasing agent (NDRA) and hence...
11 KB (794 words) - 13:48, 30 March 2025
A norepinephrine and dopamine disinhibitor (NDDI or NDD) is a drug that acts at specific sites to disinhibit downstream norepinephrine and dopamine release...
6 KB (564 words) - 22:42, 7 March 2025
4-Hydroxy-3-methoxyamphetamine (category Serotonin-norepinephrine-dopamine releasing agents)
as a monoamine releasing agent in vitro. Nonetheless, HMA has been found to induce the release of serotonin, norepinephrine, and dopamine with EC50Tooltip...
5 KB (367 words) - 05:30, 9 April 2025
Phenethylamine (category Norepinephrine-dopamine releasing agents)
its action at their common biomolecular targets, is a releasing agent of norepinephrine and dopamine. It is roughly equipotent to amphetamine in this regard...
56 KB (5,432 words) - 19:06, 22 May 2025
Methamphetamine (category Norepinephrine-dopamine releasing agents)
Similarly, norepinephrine–dopamine reuptake inhibitors (NRIs) like methylphenidate and bupropion prevent norepinephrine and dopamine release induced by...
170 KB (16,644 words) - 03:16, 21 May 2025
3,4-Ethylenedioxymethcathinone (category Serotonin-norepinephrine-dopamine releasing agents)
serotonin–norepinephrine–dopamine releasing agent (SNDRA). Its EC50Tooltip half-maximal effective concentration values for induction of monoamine release are...
5 KB (369 words) - 13:36, 11 April 2025
3,4-Dimethoxymethamphetamine (category Serotonin-norepinephrine-dopamine releasing agents)
amphetamine chemical classes. It appears to act as a serotonin–norepinephrine–dopamine releasing agent (SNDRA), although it is significantly less potent than...
2 KB (97 words) - 02:16, 11 April 2025
Mephedrone (category Serotonin-norepinephrine-dopamine releasing agents)
Partilla JS, Baumann MH, et al. (March 2019). "The dopamine, serotonin and norepinephrine releasing activities of a series of methcathinone analogs in...
142 KB (13,691 words) - 03:27, 21 May 2025
MDMA (category Serotonin-norepinephrine-dopamine releasing agents)
acts as a monoamine releasing agent (MRA). The drug is specifically a well-balanced serotonin–norepinephrine–dopamine releasing agent (SNDRA). To a lesser...
240 KB (22,951 words) - 20:35, 22 May 2025
2-Aminoacetophenone (category Norepinephrine-dopamine releasing agents)
concentration of 10,000 nM. Hence, phenacylamine acts as a norepinephrine–dopamine releasing agent (NDRA). Despite its activity in vitro however, phenacylamine...
7 KB (490 words) - 19:25, 30 March 2025